top of page

The Secret to

Turning Your Dreams Into a Reality! #4

with Cindy Eckert

3.jpg
Lips Button Graphic.png

Cindy Eckert sold her revolutionary company for 1 BILLION DOLLARS! How did she do it?! You won't BELIEVE this incredible story! Robin interviews Cindy on how she developed the first FDA-approved drug for low sexual desire in women. This product flipped the way that the industry approached women's sexual health and continues to change it today! Cindy's mission is simple: she wants women and men to have equal consideration in the bedroom. Robin dives into the nuances of Cindy's business, what drove her to keep going in the face of rejection, and how she was able to smash the glass ceiling (or the "pink ceiling," as Cindy calls it)! This conversation is highly inspirational, motivating, and- as always- FUN! Stay for the end to play a hilarious game with Robin and Cindy.

Stitcher_FullColor.png
apple-podcast-png-podcasts-app-icon-300.
file-spotify-logo-png-4.png
radiopublic-flag-red_3x.png
801087_i-heart-radio-logo-png.png
castbox_edited.png
7.jpg
9.jpg
4.jpg
11.jpg
10.jpg
2.jpg

Cindy Eckert, businesswoman, entrepreneur

Over a distinguished 24-year career in healthcare, in only the last 10 she has started and sold two businesses for more than $1.5B. First Slate Pharmaceuticals, which redefined long-acting testosterone treatment for men then Sprout Pharmaceuticals which broke through with the first ever FDA-approved drug for low sexual desire in women — dubbed “female Viagra” by the media. After selling the company for $1B in 2015, she successfully fought to get the drug back and launch it on her own terms.

 

Cindy has made waves, and made her own success, creating mission-driven companies that deliver big. Her results have become a widely covered business success story featured in major media outlets. She is most proud of helping others take command. The profoundly positive impact those companies have made in people’s lives is what keeps her coming back for more.

 

More info at: www.thepinkceiling.com 

bottom of page